DRRX

DRRX

USD

DURECT Corporation Common Stock

$1.910-0.020 (-1.036%)

Precio en Tiempo Real

Healthcare
Drug Manufacturers - Specialty & Generic
Estados Unidos

Gráfico de Precios

No hay datos de gráfico disponibles

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.930

Máximo

$1.910

Mínimo

$1.910

Volumen

N/A

Fundamentos de la Empresa

Capitalización de Mercado

59.3M

Industria

Drug Manufacturers - Specialty & Generic

País

United States

Estadísticas de Negociación

Volumen Promedio

1.36M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.4801Actual $1.910Máximo $2.64

Noticias Relacionadas

AccessWire

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

LAVAL, QC AND CUPERTINO, CA / ACCESS Newswire / August 26, 2025 / Bausch Health Companies Inc. , a global, diversified pharmaceutical company, and DURECT Corporation today announced that

Ver más
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Ver más
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VBTX, PVBC, DRRX on Behalf of Shareholders
PR Newswire

DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the second quarter ended June 30, 2025 and provided an update on the...

Ver más
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.